Joe Wiley

Chief Executive Officer at AMRYT PHARMA PLC

55 year

Health Technology

Finance

Consumer Services

Profile

Joseph A. Wiley was the founder of Amryt Pharma Holdings Ltd., founded in 2015, where the title held was Chief Executive Officer & Executive Director from 2016 to 2023.
Dr. Wiley is the founder of Amryt Pharma PLC, founded in 2015, holding the title of Chief Executive Officer since 2015.
Current jobs include Chief Executive Officer at Amryt Pharmaceuticals DAC, Chairman & Chief Executive Officer at Gamida Cell Ltd., and Member at the Royal College of Physicians of Ireland.
Former jobs include Chief Executive Officer at Enlarged Group, President & Director at Aegerion Pharmaceuticals, Inc., Investment Director at Aberdeen Asset Managers Private Equity from 2005 to 2008, Investment Director at Synova LLP in 2010, Director-Medical at Astellas Pharma Co. Ltd. from 2010 to 2012, Investment Manager at Inventages Venture Capital Investment, Inc, Independent Member-Supervisory Board at Innocoll AG, Member-Supervisory Board at Innocoll Biotherapeutics Holdings Ltd., and Principal at Sofinnova Investments, Inc. Education includes an MBA degree from INSEAD.

Joe Wiley active positions

Companies	Position	Start
AMRYT PHARMA PLC	Chief Executive Officer	01/08/2015
GAMIDA CELL LTD.	Chief Executive Officer	-
Amryt Pharmaceuticals DAC Amryt Pharmaceuticals DAC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Chief Executive Officer	-
Royal College of Physicians of Ireland Royal College of Physicians of Ireland Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

All active positions of Joe Wiley

Former positions of Joe Wiley

Companies	Position	End
Amryt Pharma Holdings Ltd. Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases	Founder	26/05/2023
Astellas Pharma Co. Ltd. Astellas Pharma Co. Ltd. Medical DistributorsDistribution Services Wholesales medical products	Chief Tech/Sci/R&D Officer	01/04/2012
Synova Capital LLP Synova Capital LLP Investment ManagersFinance Synova Capital invests in lower mid-market companies located in the United Kingdom with an enterprise value of EUR 20 - 250 million. The firm targets companies operating in the fields of business services, financial services, consumer brands, healthcare & education and technology sectors. It provides financing for buy-ins, buy-outs and development capital transactions with an investment size of EUR 15 - 150 million.	Private Equity Investor	01/08/2010
Aberdeen Asset Managers Private Equity Aberdeen Asset Managers Private Equity Investment ManagersFinance AAMPE is an active investor supported by the group's fundamental bottom-up research and process-driven approach. Their objective is to add value. They target UK mid-market investments ranging from GBP 10 million and GBP 50 million with a particular focus on support services, consumer and leisure, specialist manufacturing and financial services. They also have a particular interest in the environmental sector and in business services. AAMPE's key investment selection criteria within their targeted sectors are the prospective firms' management and business model and attractively priced opportunities. They eschew benchmarks and follow a team-based approach for all investment decisions.	Director of Investments	31/08/2008
Inventages Venture Capital Investment, Inc Inventages Venture Capital Investment, Inc Investment ManagersFinance Inventages Venture invests in companies located across the globe. The firm targets companies operating in the fields of diagnostics, drugs, OTC, medical and functional foods, nutraceuticals and enabling technologies. It provides financing for seed and early stage capital requirements.	Private Equity Investor	06/03/2006

See the detail of Joe Wiley's experience

Training of Joe Wiley

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joe Wiley's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	15
Aegerion Pharmaceuticals, Inc. Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases	Health Technology
Sofinnova Investments, Inc. Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements.	Finance
Aberdeen Asset Managers Private Equity Aberdeen Asset Managers Private Equity Investment ManagersFinance AAMPE is an active investor supported by the group's fundamental bottom-up research and process-driven approach. Their objective is to add value. They target UK mid-market investments ranging from GBP 10 million and GBP 50 million with a particular focus on support services, consumer and leisure, specialist manufacturing and financial services. They also have a particular interest in the environmental sector and in business services. AAMPE's key investment selection criteria within their targeted sectors are the prospective firms' management and business model and attractively priced opportunities. They eschew benchmarks and follow a team-based approach for all investment decisions.	Finance
INSEAD INSEAD Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Inventages Venture Capital Investment, Inc Inventages Venture Capital Investment, Inc Investment ManagersFinance Inventages Venture invests in companies located across the globe. The firm targets companies operating in the fields of diagnostics, drugs, OTC, medical and functional foods, nutraceuticals and enabling technologies. It provides financing for seed and early stage capital requirements.	Finance
Gamida Cell Ltd. Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases	Health Technology
Synova Capital LLP Synova Capital LLP Investment ManagersFinance Synova Capital invests in lower mid-market companies located in the United Kingdom with an enterprise value of EUR 20 - 250 million. The firm targets companies operating in the fields of business services, financial services, consumer brands, healthcare & education and technology sectors. It provides financing for buy-ins, buy-outs and development capital transactions with an investment size of EUR 15 - 150 million.	Finance
Enlarged Group
Astellas Pharma Co. Ltd. Astellas Pharma Co. Ltd. Medical DistributorsDistribution Services Wholesales medical products	Distribution Services
Innocoll AG Innocoll AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals	Health Technology
Royal College of Physicians of Ireland Royal College of Physicians of Ireland Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Innocoll Holdings Plc Innocoll Holdings Plc Pharmaceuticals: MajorHealth Technology Develops specialty pharmaceuticals	Health Technology
Amryt Pharmaceuticals DAC Amryt Pharmaceuticals DAC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Amryt Pharma Holdings Ltd. Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases	Health Technology
Amryt Pharma Plc Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company and develops and commercializing treatments for patients with rare & orphan diseases	Health Technology

See company connections